Allie Casey

Nurse navigators at Sarah Cannon use oncology pathways to help ensure patient access to seamless care across the cancer continuum.

Rami Komrokji, MD, discusses the advances that have been made in myelodysplastic syndrome MDS in the past few years, as well as the MDS Clinical Research Consortium and its importance.

Ovarian cancer expert, David M. Gershenson, MD, from University of Texas MD Anderson Cancer Center discusses three treatments for some of the rare types of ovarian cancers and the challenges to treating these diseases.

Karley Trautman, DNP, ANP-BC, explains her efforts to improve the rates of venous thromboembolism (VTE), as well as the rates of recurrence of VTE in the Blood Cancer and Bone Marrow Transplant program of University of Colorado Hospital.

Moving Forward Together 3 is a study evaluating how to get breast cancer survivors exercising, by using other breast cancer survivors as coaches.

Barriers to clinical trials can more acutely affect patients in minority and other groups -- such as the elderly.

The Visible Ink program at Memorial Sloan Kettering Cancer Center helps patients and survivors express their stories and feelings through writing.

Researchers found that the rate of suicide in patients with lung cancer is much higher than those with other types of cancer.

As the Senate revealed their healthcare reconciliation bill, healthcare advocacy and profession organizations weighed in.

The use of standard criteria for palliative care consultations in patients with advanced cancer is associated with an improvement in the quality of oncology care, as well as a reduction in downstream healthcare utilization.

By developing a training program, nurses in radiation at Johns Hopkins Hospital were able to eliminate the use of anasthesia for pediatric patients.

A recent survey found that women with ovarian cancer are uncertain of what to expect, and experience a gap when communicating with healthcare providers.

A recent study found that gliomas are less common among patients with higher blood sugar and diabetes.

A recent study provides more evidence toward the link between electronic cigarette use and bladder cancer risk.

More Stage I cancers were diagnosed after the passage of the Affordable Care Act (ACA), also known as Obamacare, within five screenable disease types: colorectal cancer, female breast cancer, cervical cancer, lung cancer, and prostate cancer).

A recent study has found that, when it comes to physical activity recommendations, there is a disparity between what patients want and what their providers do.

Nurses at Rutgers Cancer Institute of New Jersey reviewed their patient education program.

A recent study evaluated the effect of red light on hair growth in women with breast cancer.

Thought the incidence of breast cancer has decreased in many US racial/ethnic populations, the rate has increased in the Asian-American population.

A recent review has found substantial evidence linking androgen deprivation therapy (ADT) to dementia in patients with prostate cancer.

Tricia Strusowski, MS, RN, discusses the importance of a nurse navigator to both the patient and the center.

With antiretroviral drugs easing the burden of AIDS-defining cancers in HIV-positive patients, the most common cancers in this population are expected to shift to those associated with aging.

A new policy statement from ASCO addresses the specific needs in oncology of patients in the sexual and gender minority populations.

A recent study has found that pembrolizumab (Keytruda) may be effective in treating patients with mesothelioma.

For patients with breast cancer on aromatase inhibitors, preventive sexual counseling can reduce sexual dysfunction, and it should be provided earlier in treatment, with support from providers.

Today, the US House of Representatives is set to vote on the American Health Care Act which would repeal the Affordable Care Act, ACA or Obamacare.

A recent study evaluated how muscle mass can be used to predict which patients will experience toxicities from chemotherapy and to what extent.

A recent study found that neurofeedback brain training could be effective in reducing chemotherapy-induced peripheral neuropathy (CIPN).

After chemotherapy proved unsuccessful, one patient entered a clinical trial of a new combination for immunotherapy for her ovarian cancer.

Alix Beaupierre, RN, BSN, OCN, transplant nurse coordinator at Moffitt Cancer Center, discusses the patient education program she led for a CAR T-cell therapy clinical trial.